Asymmetric synthesis of novel isoindolines: Azasaccharide mimics as potential enzyme inhibitors

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 7, 2001, Pages 945-948

  Ewing, D F ^a   Len, C ^b   Mackenzie, G ^a   Petit, J P ^b   Ronco, G ^b   Villa, P ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHOXYISOINDOLINE DERIVATIVE; 2',3' DIDEOXY 2',3' DIDEHYDRONUCLEOSIDE DERIVATIVE; AMINOSUGAR; ANTIRETROVIRUS AGENT; CARBOHYDRATE DERIVATIVE; ENZYME INHIBITOR; GLYCOSIDASE INHIBITOR; HETEROCYCLIC COMPOUND; INDOLE DERIVATIVE; NUCLEOSIDE DERIVATIVE; PHTHALALDEHYDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHIRALITY; DRUG SYNTHESIS; ENANTIOMER; HYDROXYLATION; MOLECULAR MIMICRY; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

DIDEOXYNUCLEOSIDES; ENZYME INHIBITORS; INDOLES;

EID: 0034938408     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011776351     Document Type: Article

References (10)

1. The anti-HTLV-III (anti-HIV) and cytoxic activity of 2′,3′-didehydro-2′,3′-dideoxyribonucleosides: A comparison with their parental 2′,3′-dideoxyribonucleosides
2. Enantiomeric syntheses of conformationally restricted D- and L-2′,3′-dideoxy-2′,3′-endo-methylene nucleosides from carbohydrate chiral templates
3. Nucleoside analogues with a novel glycone based on the benzo[c]furan core
4. Stereoisomeric pyrimidine nucleoside analogues based on the dihydrobenzo[c]furan core
5. Structural studies of the anti-HIV agent 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T)
6. First synthesis of 4′-acetamido-2′-deoxythymidine
7. Enzyme-catalyzed organic synthesis: Practical routes to aza sugars and their analogs for use as glycoprocessing inhibitors
8. Nucleosides with a twist. Can fixed forms of sugars ring pucker influence biological activity in nucleosides and oligonucleotides?
9. A new route to isoindole intermediates
10. Azasugars: Chemistry and their biological activity as potential anti-HIV drugs